To the full analysis
Ibiden stock: growth
4062.TIbiden reported $2.61B in revenue for fiscal 2026, up 12.7% on the prior year, up 5.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
0.2%
per year from 2007 to 2026, per share 0.5%
Earnings (Annual rate)
1.5%
per year from 2007 to 2026, per share 1.8%
Free cash flow (Annual rate)
−17.8%
per year from 2007 to 2026, per share −17.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 5.2% | 2.9% | 0.2% |
| Revenue per share | 5.2% | 2.6% | 0.5% |
| Earnings | 19.9% | 23.8% | 1.5% |
| Earnings per share | 19.9% | 23.5% | 1.8% |
| Free cash flow | no data | −33.4% | −17.8% |
| Free cash flow per share | no data | −33.5% | −17.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $2.5B | $302.49M | $75.03M |
| 2008 | $2.59B | $288.16M | $172.09M |
| 2009 | $1.94B | −$54.55M | −$8.38M |
| 2010 | $1.72B | $74.49M | $221.5M |
| 2011 | $1.91B | $123.61M | $154.49M |
| 2012 | $1.88B | $66.67M | −$126.51M |
| 2013 | $1.79B | $13.98M | −$12.82M |
| 2014 | $1.94B | $109.45M | $88.07M |
| 2015 | $1.99B | $119.65M | $42.23M |
| 2016 | $1.97B | $47.15M | $104.9M |
| 2017 | $1.67B | −$393.55M | $20.38M |
| 2018 | $1.88B | $72.53M | $51.8M |
| 2019 | $1.82B | $20.7M | −$30.58M |
| 2020 | $1.85B | $70.94M | −$69.96M |
| 2021 | $2.03B | $160.92M | −$227.91M |
| 2022 | $2.51B | $258.19M | $264.08M |
| 2023 | $2.61B | $326.79M | $140.99M |
| 2024 | $2.32B | $197.19M | $374.3M |
| 2025 | $2.31B | $211.05M | −$492.11M |
| 2026 | $2.61B | $398.96M | $1.81M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 30 Sep 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.